We are live on
!
Find out more
KA
Kearns & Associates Portfolio holdings
AUM
$214M
1-Year Est. Return
23.8%
This Fund
S&P 500
This Quarter
Est. Return
+10.34%
1 Year Est. Return
+23.8%
3 Year Est. Return
+69.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$174M
AUM Growth
+$20.3M
(+13%)
Cap. Flow
+$4.48M
Cap. Flow
% of AUM
2.57%
Top 10 Holdings %
Top 10 Hldgs %
88.1%
Holding
45
New
3
Increased
7
Reduced
2
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.83M |
| 2 |
Fidelity Total Bond ETF
FBND
|
+$702K |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$622K |
| 4 |
SPDR Gold Trust
GLD
|
+$207K |
| 5 |
Morgan Stanley
MS
|
+$184K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$201K |
| 2 |
Thermo Fisher Scientific
TMO
|
+$13.4K |
| 3 |
Vanguard Real Estate ETF
VNQ
|
+$5.64K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 3.96% |
| 2 | Technology | 3.84% |
| 3 | Healthcare | 1.94% |
| 4 | Communication Services | 1.19% |
| 5 | Consumer Discretionary | 0.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
JPMorgan Chase
JPM
$916B
| $568K | 0.33% |
1,960
| – | – |
|
27
Wells Fargo
WFC
$254B
| $561K | 0.32% |
7,000
| – | – |
|
28
Herbalife
HLF
$1.3B
| $490K | 0.28% |
56,900
| – | – |
|
29
Occidental Petroleum
OXY
$55.7B
| $484K | 0.28% |
11,518
+718
| +7% | +$30K |
|
30
Johnson Controls International
JCI
$85.1B
| $475K | 0.27% |
4,500
| – | – |
|
31
Capital One
COF
$128B
| $462K | 0.26% |
2,170
| – | – |
|
|
32
Thermo Fisher Scientific
TMO
$214B
| $459K | 0.26% |
1,133
-32
| -3% | -$13.4K |
|
|
33
Vanguard Real Estate ETF
VNQ
$39.9B
| $446K | 0.26% |
5,013
-64
| -1% | -$5.64K |
|
34
Stryker
SYK
$135B
| $380K | 0.22% |
960
| – | – |
|
35
iShares Core S&P 500 ETF
IVV
$858B
| $376K | 0.22% |
605
| – | – |
|
36
Walt Disney
DIS
$171B
| $375K | 0.21% |
3,020
| – | – |
|
37
Equinix
EQIX
$99.4B
| $306K | 0.18% |
385
| – | – |
|
38
Qualcomm
QCOM
$164B
| $303K | 0.17% |
1,905
| – | – |
|
39
Baker Hughes
BKR
$58.3B
| $288K | 0.16% |
7,500
| – | – |
|
40
ConocoPhillips
COP
$144B
| $223K | 0.13% |
2,482
| – | – |
|
41
Lowe's Companies
LOW
$121B
| $222K | 0.13% |
1,000
| – | – |
|
|
42
Morgan Stanley
MS
$319B
| $211K | 0.12% |
+1,500
| New | +$184K |
|
|
43
SPDR Gold Trust
GLD
$131B
| $209K | 0.12% |
+685
| New | +$207K |
|
44
Union Pacific
UNP
$174B
| $207K | 0.12% |
900
| – | – |
|
|
45
Progressive
PGR
$128B
| – | – |
-710
| Closed | -$201K |
|
Similar funds
TSS
CMBA
RC
VCM
IH
IAM
CCM
VFG
Kearns & Associates's Q2 2025 Portfolio in Review
As of Q2 2025, Kearns & Associates held 45 positions worth $174M, up 13% from $154M the previous quarter. Its ten largest holdings account for 88% of the portfolio.
Kearns & Associates's Q2 2025 filing shows 3 new, 7 increased, 2 reduced and 1 closed positions. Its largest new stake was Fidelity Total Bond ETF: 15,515 shares worth $710K. The largest sale was Progressive, an estimated $201K.
By sector, the portfolio is most concentrated in Financials at 4% of assets, down from 4% a quarter earlier, followed by Technology and Healthcare.
- Kearns & Associates's largest Q2 2025 buy was Fidelity Total Bond ETF: 15,515 shares worth $710K.
- Kearns & Associates added most to Vanguard Morningstar Total Stock Market ETF in Q2 2025, an estimated $2.83M increase.
- Kearns & Associates's biggest Q2 2025 reduction was Thermo Fisher Scientific, cutting an estimated $13.4K.
- Kearns & Associates fully exited Progressive in Q2 2025, selling an estimated $201K.
- Kearns & Associates's ten largest holdings make up 88% of its $174M portfolio in Q2 2025.
- Kearns & Associates opened 3 new positions and closed 1 in Q2 2025.
- Kearns & Associates's portfolio value rose 13% quarter-over-quarter to $174M.
Based on Kearns & Associates's 13F filing for Q2 2025, filed 9 Jul 2025.